Comparison of Efficiencies of Non-invasive Prenatal Testing, Karyotyping, and Chromosomal Micro-Array for Diagnosing Fetal Chromosomal Anomalies in the Second and Third Trimesters. Zhu Yiyang et al. Frontiers in genetics 2019 1069

Main|Search|PHGKB




Last Posted: Apr 04, 2019

---

• Comparison of Efficiencies of Non-invasive Prenatal Testing, Karyotyping, and Chromosomal Micro-Array for Diagnosing Fetal Chromosomal Anomalies in the Second and Third Trimesters.
  Zhu Yiyang et al. Frontiers in genetics 2019 1069
• No US commercial laboratories fully meet guidance for noninvasive prenatal screening
  Mass General Hospital, April 2, 2019
• From diagnostic yield to clinical impact: a pilot study on the implementation of prenatal exome sequencing in routine care.
  de Koning Maayke A et al. Genetics in medicine : official journal of the American College of Medical Genetics 2019 Mar
• The continuing saga of patents and non-invasive prenatal testing.
  Hawkins Naomi et al. Prenatal diagnosis 2019 Mar
• Value of increased nuchal translucency in the era of noninvasive prenatal testing with cell-free DNA.
  Holzer Iris et al. International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics 2019 Mar
• Lessons from exome sequencing in prenatally diagnosed heart defects: a basis for prenatal testing.
  Westphal Dominik S et al. Clinical genetics 2019 Mar
• Noninvasive prenatal testing for chromosome aneuploidies and subchromosomal microdeletions/microduplications in a cohort of 8141 single pregnancies.
  Hu Hua et al. Human genomics 2019 Mar 13(1) 14
• The Impact of Insurance Coverage on the Prenatal Genetic Counseling Process: An Exploration of Genetic Counselors' Experiences with TRICARE.
  Brown Jordan et al. Prenatal diagnosis 2019 Mar
• The consequences of implementing non-invasive prenatal testing with cell-free foetal DNA for the detection of Down syndrome in the Spanish National Health Service: a cost-effectiveness analysis.
  Bayón J C et al. Cost effectiveness and resource allocation : C/E 2019 176
• Noninvasive Prenatal Testing for Trisomies 21, 18, and 13, Sex Chromosome Aneuploidies, and Microdeletions: A Health Technology Assessment.
  et al. Ontario health technology assessment series 2019 19(4) 1-166

more